Literature DB >> 2191313

Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).

K Tojo1, S Sakai, T Miyahara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2191313

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  3 in total

Review 1.  An update on LDL apheresis for nephrotic syndrome.

Authors:  Rupesh Raina; Vinod Krishnappa
Journal:  Pediatr Nephrol       Date:  2018-09-14       Impact factor: 3.714

2.  Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients.

Authors:  Mohammad Al-Mousily; Oana Nicoara; David T Selewski; Katherine Twombley
Journal:  Pediatr Nephrol       Date:  2021-08-28       Impact factor: 3.714

3.  Dextran-Sulfate Plasma Adsorption Lipoprotein Apheresis in Drug Resistant Primary Focal Segmental Glomerulosclerosis Patients: Results From a Prospective, Multicenter, Single-Arm Intervention Study.

Authors:  Rupesh Raina; Vinod Krishnappa; Cheryl Sanchez-Kazi; Alejandro Quiroga; Katherine E Twombley; Robert Mathias; Megan Lo; Ronith Chakraborty; Shefali Mahesh; Julia Steinke; Timothy Bunchman; Joshua Zaritsky
Journal:  Front Pediatr       Date:  2019-12-03       Impact factor: 3.418
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.